Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity

View source ↗

Summary

A recruiting clinical trial (MI-DEAR) studies whether fremanezumab for migraine with depressive symptoms reduces caregiver burden and improves couple reciprocit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ajovy (fremanezumab)

Snippet

Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico | Conditions: Migraine | Status: RECRUITING